Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation

References

• Acharya G, Shin CS, Vedantham K, McDermott M, Rish T, Hansen K, Fu Y, Park K. A study of drug release from homogeneous PLGA microstructures. J Control Release 2010; 146(2)201–6
   PubMedGoogle Scholar
• Bilati U, Allémann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005; 24(1)67–75
   PubMed Web of Science ®Google Scholar
• Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomed 2006; 1(2)117–28
   PubMed Web of Science ®Google Scholar
• Catalioto RM, Triolo A, Giuliani S, Altamura M, Evangelista S, Maggi CA. Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier. J Pharm Sci 2008; 97(9)4087–100
   PubMedGoogle Scholar
• Cetin M, Aktas Y, Vural I, Capan Y, Dogan LA, Duman M, Dalkara T. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Deliv 2007; 14(8)525–9
   PubMed Web of Science ®Google Scholar
• Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech 2010; 11(3)1250–6
   PubMed Web of Science ®Google Scholar
• Cetin M, Youn YS, Capan Y, Lee KC. Preparation and characterization of salmon calcitonin-biotin conjugates. AAPS PharmSciTech 2008; 9(4)1191–7
   PubMedGoogle Scholar
• Cholewinski M, Lückel B, Horn H. Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison. Pharm Acta Helv 1996; 71(6)405–19
   PubMedGoogle Scholar
• Cruz L, Assumpção E, Andrade SF, Conrado DJ, Kulkamp IC, Guterres SS, Pohlmann AR. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats. Eur J Pharm Sci 2010; 40(5)441–7
   PubMedGoogle Scholar
• Dawes GJ, Fratila-Apachitei LE, Mulia K, Apachitei I, Witkamp GJ, Duszczyk J. Size effect of PLGA spheres on drug loading efficiency and release profiles. J Mater Sci – Mater Med 2009; 20(5)1089–94
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 2006; 116(1)1–27
   PubMed Web of Science ®Google Scholar
• Devarajan PV, Sonavane GS. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carrier. Drug Dev Ind Pharm 2007; 33(2)101–11
   PubMed Web of Science ®Google Scholar
• Eaimtrakarn S, Itoh Y, Kishimoto J, Yoshikawa Y, Shibata N, Murakami M, Takada K. Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein. Biomaterials 2002; 23(1)145–52
   PubMedGoogle Scholar
• Eaimtrakarn S, Itoh Y, Kishimoto JI, Yoshikawa Y, Shibata N, Takada K. Retention and transit of intestinal mucoadhesive films in rat small intestine. Int J Pharm 2001; 224(1–2)61–7
   PubMed Web of Science ®Google Scholar
• Eerikäinen H, Peltonen L, Raula J, Hirvonen J, Kauppinen EI. Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method. AAPS PharmSciTech 2004; 5(4)e68
   Google Scholar
• European pharmacopoeia. 2001. 3rd edition (Suppl.). Strasbourg Cedex, France: Council of Europe, p.S526
   Google Scholar
• Garcia-Fuentes M, Prego C, Torres D, Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci 2005; 25(1)133–43
   PubMed Web of Science ®Google Scholar
• Glowka E, Sapin-Minet A, Leroy P, Lulek J, Maincent P. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles. J Microencapsul 2010; 27(1)25–36
   PubMed Web of Science ®Google Scholar
• Guggi D, Bernkop-Schnürch A. In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases. Int J Pharm 2003; 252(1–2)187–96
   PubMedGoogle Scholar
• Guggi D, Kast CE, Bernkop-Schnürch A. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix. Pharm Res 2003; 20(12)1989–94
   PubMed Web of Science ®Google Scholar
• Hee Lee Y, Leesman GD, Makhey V, Yu H, Hu P, Perry B, Sutyak JP, Wagner EJ, Falzone LM, Stern W, et al. Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs. Eur J Pharm Biopharm 2000; 50(2)205–11
   PubMed Web of Science ®Google Scholar
• Hirai S, Yasbiki T, Mima H. Effect of surfactants to nasal absorption of insulin in rats. Int J Pharm 1981; 9: 165–72
   Web of Science ®Google Scholar
• International Conference on Harmonization (ICH). Q2b: Validation of analytical procedures: Methodology. US FDA Fed Reg 1997; 62: 27463
   Google Scholar
• Jawahar N, Eagappanath T, Venkatesh N, Jubie S, Samanta MK. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent. Int J PharmTech Res 2009; 1(2)390–3
   Google Scholar
• Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?. Eur J Pharm Biopharm 2000; 50(1)147–60
   PubMed Web of Science ®Google Scholar
• Jung TS, Kwon BS, Lee HE, Kim AY, Lee MJ, Park CR, Kang HK, Kim YD, Lee SK, Kang JS, et al. Enhanced oral absorption of salmon calcitonin-encapsulated PLGA nanoparticles by adding organic substances. Korean J Chem Eng 2009; 26(1)131–5
   Google Scholar
• Karn PR, Vanić Z, Pepić I, Skalko-Basnet N. Mucoadhesive liposomal delivery systems: The choice of coating material. Drug Dev Ind Pharm 2011; 37(4)482–8
   PubMed Web of Science ®Google Scholar
• Kim BK, Hwang SJ, Park JB, Park HJ. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul 2002; 19(6)811–22
   PubMed Web of Science ®Google Scholar
• Kuksal A, Tiwary AK, Jain NK, Jain S. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSciTech 2006; 7(1)E1
   PubMed Web of Science ®Google Scholar
• Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao XJ. PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers. J Control Release 2001; 71(3)287–96
   PubMedGoogle Scholar
• Li JK, Wang N, Wu XS. Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery. J Control Release 1998; 56(1–3)117–26
   PubMed Web of Science ®Google Scholar
• Lopedota A, Trapani A, Cutrignelli A, Chiarantini L, Pantucci E, Curci R, Manuali E, Trapani G. The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. Eur J Pharm Biopharm 2009; 72(3)509–20
   PubMed Web of Science ®Google Scholar
• Makhlof A, Werle M, Tozuka Y, Takeuchi H. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J Control Release 2011; 149(1)81–8
   PubMed Web of Science ®Google Scholar
• Mansoor S, Youn YS, Lee KC. Oral delivery of mono-PEGylated sCT (Lys18) in rats: Regional difference in stability and hypocalcemic effect. Pharm Dev Technol 2005; 10(3)389–96
   PubMed Web of Science ®Google Scholar
• Mark P, Ettinger MD. Aging bone and osteoporosis strategies for preventing fractures in the elderly. Arch Intern Med 2003; 163: 2237–46
   PubMedGoogle Scholar
• Mohanraj VJ, Chen Y. Nanoparticles – a review. Trop J Pharm Res 2006; 5(1)561–73
   Google Scholar
• Morishita I, Morishita M, Takayama K, Machida Y, Nagai T. Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100. Int J Pharm 1993; 91(1)29–37
   Google Scholar
• Mukherjee B, Santra K, Pattnaik G, Ghosh S. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int J Nanomed 2008; 3(4)487–96
   PubMed Web of Science ®Google Scholar
• Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release 2011; 153(2)106–16
   PubMed Web of Science ®Google Scholar
• Pinto RC, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine 2006; 2(2)53–65
   Google Scholar
• Rowe RC, Sheskey PJ, Owen SC, (eds.). 2006. Handbook of pharmaceutical excipients. London, Washington: Pharmaceutical Press and American Pharmacists Association
   Google Scholar
• Saha P, Goyal AK, Rath G. Formulation and evaluation of chitosan-based ampicillin trihydrate nanoparticles. Trop J Pharm Res 2010; 9(5)483–8
   Web of Science ®Google Scholar
• Sakuma S, Suzuki N, Kikuchi H, Hiwatari K-I, Arikawa K, Kishida A, Akashi M. Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches. Int J Pharm 1997; 149(1)93–106
   Web of Science ®Google Scholar
• Samstein RM, Perica K, Balderrama F, Look M, Fahmy TM. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials 2008; 29(6)703–8
   PubMed Web of Science ®Google Scholar
• Saremi S, Atyabi F, Akhlaghi SP, Ostad SN, Dinarvand R. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: Preparation, in vitro and ex vivo evaluation. Int J Nanomed 2011; 6: 119–28
   PubMed Web of Science ®Google Scholar
• Sarmento B, 2008. The oral delivery of therapeutic proteins [Online]. Available at: http://www.scitopics.com/The_oral_delivery_of_therapeutic_proteins.html. Accessed 15 March 2011
   Google Scholar
• Shah RB, Khan MA. Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: Transport mechanism using Caco-2 cell monolayer. AAPS J 2004; 6(4)e31
   Google Scholar
• Shaji J, Patole V. Protein and peptide drug delivery: Oral approaches. Indian J Pharm Sci 2008; 70: 269–77
   PubMed Web of Science ®Google Scholar
• Sigurdsson HH, Knudsen E, Loftsson T, Leeves N, Sigurjonsdottir JF, Másson M. Mucoadhesive sustained drug delivery system based on cationic polymer and anionic cyclodextrin/triclosan complex. J Inclusion Phenom Macrocyclic Chem 2002; 44: 169–72
   Google Scholar
• Sinko PJ, Smith CL, McWhorter LT, Stern W, Wagner E, Gilligan JP. Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats. J Pharm Sci 1995; 84(11)1374–8
   PubMed Web of Science ®Google Scholar
• Song IS, Chung SJ, Shim CK. Contribution of ion pair complexation with bile salts to biliary excretion of organic cations in rats. Am J Physiol Gastrointest Liver Physiol 2001; 281(2)G515–25
   Google Scholar
• Song KH, Chung SJ, Shim CK. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release 2005; 106(3)298–308
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, Cai Z, Li Y, Chen Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 2008; 69(2)445–53
   PubMed Web of Science ®Google Scholar
• Sood A, Panchagnula R. Peroral route: An opportunity for protein and peptide drug delivery. Chem Rev 2001; 101(11)3275–303
   PubMed Web of Science ®Google Scholar
• Takada K, Ushirogawa Y. Effect of pH, dietary proteins and trypsin inhibitors on the hydrolytic rate of human granulocyte colony-stimulating factor (G-CSF) by rat digestive enzymes. J Pharmacobiodyn 1991; 14(7)363–70
   PubMedGoogle Scholar
• Varaprasad Reddy M, Sudheer Babu I. Chitosan versus thiolated chitosans as polymers in mucoadhesive drug delivery – a comparative study. IRJP 2010; 1(1)81–8
   Google Scholar